- What is the Drug Residue Prevention Program Cooperative Agreement?
- What are its goals?
- Who are the current awardees?
- Who can I contact for more information?
- Drug Residue Prevention Program Cooperative Agreement Program Fact Sheet (Version July 2022)
The primary focus of this cooperative agreement is to initiate or improve state drug residue prevention programs that communicate proper drug use and effective management practices to prevent drug residues in animal-derived foods in their jurisdiction. This program is a more effective alternative of reaching out to industry and the community to promote compliance, to prevent violations, and provide an awareness of proper drug use or prevention of illegal drug residues. This cooperative agreement program will allow for state program development in drug residue prevention, encourage resource utilization, enhance information sharing and provide infrastructure building.
Funds to be used on educational outreach activities and training can include, but are not limited to the following:
- Best practice visits
- Developing materials needed to increase knowledge of, and compliance with, approved drug use
- Education in effective management practices and on-farm practices
- Developing materials or events for drug residue prevention and awareness
- Provide information on extra label drug use regulations and prohibitions
- Understanding of treated food-producing animal management
- Fund adequate control measures
- Distribution of materials at meetings, websites and other broad efforts to reach the industry
This cooperative agreement provides a growing opportunity to enhance public health through partnerships involving joint efforts between the federal government and the states.
The total project period for this program is up to three years with variable tier funding up to $175,000 a year, based on specific criteria stated on the funding opportunity announcement. The start date for this program began September 1, 2018. The total project award for all three years is over $3 million.
The primary goal of this program is to emphasize drug residue prevention through outreach, education, and training. This cooperative agreement program provides an opportunity to protect public health on the front end with the FDA encouraging the public to be proactive on violations as opposed to being reactive to violations through educational outreach and training.
- Effective management of animal treatment by laypersons (i.e. producers) and practitioners is expected
- Knowledge of proper drug use and extra label drug use regulations
- A reduction in illegal drug residues is anticipated in food-producing animals
United States Map displaying 7 FDA funded Drug Residue Prevention Program Cooperative agreement states: CA, IA, IN, MN, NY, OH, VA
- 7 contracts with state government regulatory agencies.
- 7 states are covered in these contracts.
- Over $840K in funding under this cooperative agreement program.
Specific questions on this program can be directed to the appropriate Office of Partnerships' contact within the Division of Partnership Investments and Agreements. Please visit the Office of Partnerships Contacts webpage to obtain a downloaded version of the staffing roster.
You can also find contact information and more on the funding opportunity announcement.
General questions can be directed to the Office of Partnerships' general mailbox: firstname.lastname@example.org.